While the HHS public health emergency is ending, COVID-19 remains a high priority and the U.S. Food and Drug Administration will remain engaged with numerous activities to protect and promote public health.
Federal, Provincial, Territorial Public Health Response Plan for Ongoing Management of COVID-19
FDA Roundup: May 12, 2023 - US FDA
Science and Engineering Laboratories: Updates from FDA/CDRH - US FDA
Fresh Arrivals: Latest Products in Our Outlet with Great Discounts - Nae Vegan Shoes
AnaBot: Enhance ChatGPT Conversations & Insights
Frontiers China's Public Health Policies in Response to COVID-19: From an “Authoritarian” Perspective
How Penn Medicine Epidemiologists Prepared for Future Pandemics
COVID-19: Pandemic Lessons Highlight Need for Public Health Situational Awareness Network
From SARS to COVID-19: the role of experience and experts in Hong Kong's initial policy response to an emerging pandemic
COVID-19 and Human Development: Assessing the Crisis, Envisioning the Recovery
FDA Roundup: May 12, 2023 - US FDA
Public Health Preparedness Capabilities: National Standards for State and Local Planning, State and Local Readiness
First lessons from government evaluations of COVID-19 responses: A synthesis
COVID-19: Current and Future Federal Preparedness Requires Fixes to Improve Health Data and Address Improper Payments
Trend Alert: 🪩 Retro Inspired Photos - Archipelago Presets